BioCentury
ARTICLE | Company News

Alexza, Ferrer sales and marketing update

January 27, 2014 8:00 AM UTC

Ferrer launched Adasuve Staccato loxapine in Spain. The launch triggered a $1 million payment to Alexza from Ferrer. The European Commission approved Adasuve last February to treat mild to moderate agitation in adults with schizophrenia or bipolar disorder. The ex-factory price in Spain is €70 ($94.89) for a single 9.1 mg dose. According to the European label, treatment is started with a single dose, with a second dose to be prescribed if necessary. The product is also available in Germany and Austria. ...